Antonietta Restuccia

Title: Antonietta Restuccia: Innovator in Targeted Effector Proteins

Introduction

Antonietta Restuccia is a prominent inventor based in Edmond, OK (US). She has made significant contributions to the field of biotechnology, particularly in the development of targeted effector proteins. Her innovative work has the potential to impact pharmaceutical formulations and therapeutic applications.

Latest Patents

Antonietta Restuccia holds a patent for "Targeted effector proteins and uses thereof." This patent describes targeted effector fusion proteins, which can include an effector protein linked to a targeting moiety. The monomer targeted effector fusion proteins can form both homogeneous and heterogeneous complexes. These proteins and their complexes can be formulated as pharmaceutical formulations, which can be administered to subjects in need.

Career Highlights

Restuccia is associated with the University of Florida Research Foundation Inc., where she continues to advance her research. Her work focuses on the intersection of protein engineering and therapeutic applications, showcasing her commitment to innovation in the life sciences.

Collaborations

Some of her notable coworkers include Sabrina Freeman and Margaret Mary Fettis, who contribute to her research endeavors and collaborative projects.

Conclusion

Antonietta Restuccia's work in targeted effector proteins exemplifies the innovative spirit of modern biotechnology. Her contributions are paving the way for new therapeutic solutions and enhancing our understanding of protein functionalities.